FDA Approves Moderna's mRNA Flu Vaccine

The U.S. Food and Drug Administration (FDA) has approved Moderna's mRNA-based vaccine for influenza. This marks a significant regulatory action in the development of mRNA technology for infectious diseases beyond COVID-19, offering a new option for flu prevention.